SM88

· Tyme, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SM88, covering 2019-07-22 to 2019-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer [Phase 1, Phase 2]